Assessment of hypertension in obstructive sleep apnea by ambulatory blood pressure monitoring: a systematic review and meta-analysis.
Journal
Blood pressure monitoring
ISSN: 1473-5725
Titre abrégé: Blood Press Monit
Pays: England
ID NLM: 9606438
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
pubmed:
23
7
2022
medline:
15
9
2022
entrez:
22
7
2022
Statut:
ppublish
Résumé
Among obstructive sleep apnea (OSA) patients, there exists a high prevalence of hypertension. Determining the optimal blood pressure (BP) monitoring modality in this population will lead to a better understanding of hypertension profiles and a more accurate diagnosis of hypertension. PubMed, Ovid/Medline, Web of Science, Scopus, Cochrane Library, and CINAHL databases were screened, and the relevant articles regarding BP monitoring in OSA patient population were selected. Studies evaluating both ambulatory (ABPM) and office BP measurements were selected to be analyzed for the hypertension diagnosis specificity of ABPM measurement in OSA patients compared with office measurements. If reported, additional information regarding white-coat, masked hypertension, and circadian BP pattern prevalence was included. A cumulative analysis of five studies revealed a prevalence of hypertension based on BP to be 44%, whereas a cumulative analysis of four studies revealed a prevalence of hypertension based on ABPM to be 66%. Excluding a study with the nighttime assessment of hypertension reduced the cumulative prevalence of hypertension in OSA patients to 59%. The cumulative prevalence of Studies demonstrated the prevalence of masked and white-coat hypertension to be 34 and 9%, respectively. As a higher prevalence of hypertension was detected by ABPM and nighttime measurement, it can be deduced that ABPM is more sensitive in determining OSA patients with hypertension, and that nighttime ABPM further increases this sensitivity. The presence of masked and white-coat hypertension in OSA patients underlines the importance of correct hypertension diagnosis as it affects further management in this population with increased cardiovascular risk.
Identifiants
pubmed: 35866496
doi: 10.1097/MBP.0000000000000613
pii: 00126097-202210000-00001
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-296Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Šiarnik P, Klobučníková K, Mucska I, Hlucháňová A, Hanus O, Turčáni P, Kollár B. Obstructive sleep apnea and hypertension: the role of gut microbiome. Vnitr Lek 2020; 66:415–419.
Floras JS. Hypertension and sleep apnea. Can J Cardiol 2015; 31:889–897.
Ozkok A, Kanbay A, Odabas AR, Covic A, Kanbay M. Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor. Clin Exp Hypertens 2014; 36:211–216.
Van Ryswyk E, Mukherjee S, Chai-Coetzer CL, Vakulin A, McEvoy RD. Sleep disorders, including sleep apnea and hypertension. Am J Hypertens 2018; 31:857–864.
Aslan G, Afsar B, Siriopol D, Kanbay A, Sal O, Benli C, et al. Cardiovascular effects of continuous positive airway pressure treatment in patients with obstructive sleep apnea: a meta-analysis. Angiology 2018; 69:195–204.
Johnson DA, Thomas SJ, Abdalla M, Guo N, Yano Y, Rueschman M, et al. Association between sleep apnea and blood pressure control among blacks. Circulation 2019; 139:1275–1284.
Cai A, Zhang J, Wang R, Chen J, Huang B, Zhou Y, Wang L. Joint effects of obstructive sleep apnea and resistant hypertension on chronic heart failure: a cross-sectional study. Int J Cardiol 2018; 257:125–130.
Kanbay A, Inonu H, Solak Y, Erden A, Uslu E, Yuksel SA, et al. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur J Intern Med 2014; 25:471–476.
Narkiewicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens 1997; 15:1613–1619.
Phillips CL, Cistulli PA. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects. Minerva Med 2006; 97:299–312.
Maricoto T, Silva EAR, Damião P, Bastos JM. The OXIMAPA study: hypertension control by ABPM and association with sleep apnea syndrome by pulse oximetry. Acta Med Port 2017; 30:93–99.
Wolf J, Hering D, Narkiewicz K. Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res 2010; 33:867–871.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62:e1–e34.
Baguet JP, Boutin I, Barone-Rochette G, Levy P, Tamisier R, Pierre H, et al. Hypertension diagnosis in obstructive sleep apnea: self or 24-hour ambulatory blood pressure monitoring? Int J Cardiol 2013; 167:2346–2347.
Baguet JP, Lévy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008; 26:885–892.
Baguet JP, Nadra M, Barone-Rochette G, Ormezzano O, Pierre H, Pépin JL. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea. Vasc Health Risk Manag 2009; 5:1063–1073.
Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005; 23:521–527.
García-Río F, Pino JM, Alonso A, Arias MA, Martínez I, Alvaro D, Villamor J. White coat hypertension in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2004; 125:817–822.
Sova M, Genzor S, Sovova M, Sovova E, Moravcova K, Nadjarpour S, Zapletalova J. High incidence of masked hypertension in patientswith obstructive sleep apnoea despite normal automatedoffice blood pressure measurement results. Adv Respir Med 2020; 88:567–573.
Wilcox I, Collins FL, Grunstein RR, Hedner J, Kelly DT, Sullivan CE. Relationship between chemosensitivity, obesity and blood pressure in obstructive sleep apnoea. Blood Press 1994; 3:47–54.
Wilcox I, Grunstein RR, Collins FL, Doyle JM, Kelly DT, Sullivan CE. Circadian rhythm of blood pressure in patients with obstructive sleep apnea. Blood Press 1992; 1:219–222.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25:603–605.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557–560.
European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1153.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105–1187.
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153:154-183.
Consensus document on non-invasive ambulatory blood pressure monitoring. The Scientific Committee. J Hypertens Suppl 1990; 8:S135-S140.
Tang O, Juraschek SP, Appel LJ, Cooper LA, Charleston J, Boonyasai RT, et al. Comparison of automated clinical and research blood pressure measurements: implications for clinical practice and trial design. J Clin Hypertens (Greenwich) 2018; 20:1676–1682.
Ahmed J, Ozorio V, Farrant M, Van Der Merwe W. Ambulatory vs office blood pressure monitoring in renal transplant recipients. J Clin Hypertens (Greenwich) 2015; 17:46-50.
Ferraris JR, Ghezzi L, Waisman G, Krmar RT. ABPM vs office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant 2007; 11:24–30.
Łątka M, Drożdż T, Kwinta P, Dąbrowska E, Pietrzyk JA, Drożdż D. [Office and 24-hour ambulatory blood pressure measurements in hypertension assessment in children with chronic kidney disease]. Przegl Lek 2016; 73:287–295.
Solak Y, Kario K, Covic A, Bertelsen N, Afsar B, Ozkok A, et al. Clinical value of ambulatory blood pressure: is it time to recommend for all patients with hypertension? Clin Exp Nephrol 2016; 20:14–22.
Kanbay M, Turkmen K, Ecder T, Covic A. Ambulatory blood pressure monitoring: from old concepts to novel insights. Int Urol Nephrol 2012; 44:173–182.
Salman LA, Shulman R, Cohen JB. Obstructive sleep apnea, hypertension, and cardiovascular risk: epidemiology, pathophysiology, and management. Curr Cardiol Rep 2020; 22:6.
Hou H, Zhao Y, Yu W, Dong H, Xue X, Ding J, et al. Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis. J Glob Health 2018; 8:010405.
Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320:479–482.
Drager LF, Diegues-Silva L, Diniz PM, Bortolotto LA, Pedrosa RP, Couto RB, et al. Obstructive sleep apnea, masked hypertension, and arterial stiffness in men. Am J Hypertens 2010; 23:249–254.
Verberk WJ, Thien T, de Leeuw PW. Masked hypertension, a review of the literature. Blood Press Monit 2007; 12:267–273.
Sakaguchi K, Horimatsu T, Kishi M, Takeda A, Ohnishi Y, Koike T, et al. Isolated home hypertension in the morning is associated with target organ damage in patients with type 2 diabetes. J Atheroscler Thromb 2005; 12:225–231.
Bobrie G, Genès N, Vaur L, Clerson P, Vaisse B, Mallion JM, Chatellier G. Is “isolated home” hypertension as opposed to “isolated office” hypertension a sign of greater cardiovascular risk? Arch Intern Med 2001; 161:2205–2211.
Palatini P. Masked hypertension: how can the condition be detected? Blood Press Monit 2004; 9:297–299.
Li L, Guo LZ, Li J, Wang Y, Liu X, Lv YH, Ma CS. White coat hypertension and obstructive sleep apnea. Sleep Breath 2015; 19:1199–1203.
Kaul U, Arambam P, Rao S, Kapoor S, Swahney JPS, Sharma K, et al. Usefulness of ambulatory blood pressure measurement for hypertension management in India: the India ABPM study. J Hum Hypertens 2020; 34:457–467.
Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens 2008; 26:1290–1299.
Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al.; International Database on Ambulatory Blood Pressure In Relation to Cardiovascular Outcomes Investigators. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010; 28:2036–2045.
Thomas SJ, Booth JN 3rd, Jaeger BC, Hubbard D, Sakhuja S, Abdalla M, et al. Association of sleep characteristics with nocturnal hypertension and nondipping blood pressure in the CARDIA Study. J Am Heart Assoc 2020; 9:e015062.
Torres G, Sánchez-de-la-Torre M, Barbé F. Relationship between OSA and hypertension. Chest 2015; 148:824–832.
Walia HK, Li H, Rueschman M, Bhatt DL, Patel SR, Quan SF, et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med 2014; 10:835–843.